ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,312 | -85.6% | 61,684 | -79.4% | 0.00% | – |
| Q4 2022 | $50,882 | -46.4% | 299,362 | -37.5% | 0.00% | – |
| Q3 2022 | $95,000 | -46.9% | 478,626 | +33.7% | 0.00% | – |
| Q2 2022 | $179,000 | -42.4% | 358,000 | -34.5% | 0.00% | – |
| Q1 2022 | $311,000 | -72.3% | 546,479 | -70.5% | 0.00% | – |
| Q4 2021 | $1,124,000 | -47.8% | 1,852,922 | -16.5% | 0.00% | – |
| Q3 2021 | $2,152,000 | +17.4% | 2,218,545 | +33.2% | 0.00% | – |
| Q2 2021 | $1,833,000 | +6.0% | 1,665,800 | -9.5% | 0.00% | – |
| Q1 2021 | $1,730,000 | +555.3% | 1,840,647 | +238.8% | 0.00% | – |
| Q4 2020 | $264,000 | +11.9% | 543,252 | +80.6% | 0.00% | – |
| Q3 2020 | $236,000 | +3833.3% | 300,835 | +2406.5% | 0.00% | – |
| Q2 2020 | $6,000 | -14.3% | 12,002 | -40.6% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 20,212 | +51.6% | 0.00% | – |
| Q4 2019 | $9,000 | -80.4% | 13,332 | -79.6% | 0.00% | – |
| Q3 2019 | $46,000 | -94.8% | 65,482 | -90.4% | 0.00% | – |
| Q2 2019 | $888,000 | +10.2% | 683,853 | +78.9% | 0.00% | – |
| Q1 2019 | $806,000 | +25.9% | 382,281 | +34.5% | 0.00% | – |
| Q4 2018 | $640,000 | -82.4% | 284,216 | -72.6% | 0.00% | -100.0% |
| Q3 2018 | $3,635,000 | +459.2% | 1,038,607 | +411.4% | 0.00% | – |
| Q2 2018 | $650,000 | -41.1% | 203,097 | -35.6% | 0.00% | – |
| Q1 2018 | $1,103,000 | -53.4% | 315,248 | -41.4% | 0.00% | -100.0% |
| Q4 2017 | $2,369,000 | +0.3% | 538,402 | +19.0% | 0.00% | 0.0% |
| Q3 2017 | $2,363,000 | +24.6% | 452,378 | +24.0% | 0.00% | – |
| Q2 2017 | $1,896,000 | +139.4% | 364,678 | +95.8% | 0.00% | – |
| Q1 2017 | $792,000 | +40.4% | 186,287 | +4.0% | 0.00% | – |
| Q4 2016 | $564,000 | -1.6% | 179,179 | +7.3% | 0.00% | – |
| Q3 2016 | $573,000 | +125.6% | 167,047 | +83.5% | 0.00% | – |
| Q2 2016 | $254,000 | +154.0% | 91,013 | +456.7% | 0.00% | – |
| Q1 2016 | $100,000 | -24.2% | 16,350 | -33.3% | 0.00% | – |
| Q4 2015 | $132,000 | +193.3% | 24,509 | +115.1% | 0.00% | – |
| Q3 2015 | $45,000 | -34.8% | 11,396 | -30.5% | 0.00% | – |
| Q2 2015 | $69,000 | -13.8% | 16,401 | -19.7% | 0.00% | – |
| Q1 2015 | $80,000 | -37.0% | 20,430 | -0.8% | 0.00% | – |
| Q4 2014 | $127,000 | -3.8% | 20,597 | -27.0% | 0.00% | – |
| Q3 2014 | $132,000 | -1.5% | 28,197 | +1.3% | 0.00% | – |
| Q2 2014 | $134,000 | – | 27,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |